US 10221161
Inhibitors of plasma kallikrein
granted A61PA61P1/00A61P1/18
Quick answer
US patent 10221161 (Inhibitors of plasma kallikrein) held by KalVista Pharmaceuticals Limited expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- KalVista Pharmaceuticals Limited
- Grant date
- Tue Mar 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61P, A61P1/00, A61P1/18, A61P11/00, A61P13/12